National key R&D program launched March 16, 2026, to accelerate nanopore sequencing for pathogen detection, enhancing speed and accuracy in identifying infectious agents.
This national program signifies a significant government investment in advanced genomic technologies for public health. Accelerating nanopore sequencing for pathogen detection can lead to faster outbreak responses, improved diagnostics, and a stronger defense against infectious diseases. It positions BGI Genomics and its partners at the forefront of this critical technological development in China.
National key R&D program launched for nanopore sequencing.
Focus on accelerating applications in pathogen infection detection.
Aims to improve speed and accuracy of identifying infectious agents.
The program is a national initiative in China, indicating a strategic focus on strengthening domestic capabilities in advanced diagnostics and public health infrastructure within East Asia.
Focus on accelerating applications in pathogen infection detection.
Aims to improve speed and accuracy of identifying infectious agents.
登录后可保存信号笔记。
登录